
How a Type 2 Diabetes Treatment Reduces Cardiovascular Risk
In recent work, Ekhzaimy et al1 took advantage of the three-channel fluorescence imaging capability of the Sapphire Biomolecular Imager to conduct a proteomics study of liraglutide treatment







